Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 141
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06456580 A Study of Telitacicept for the Treatment of Generalized Myasthenia Gra… |
Telitacicept | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | The Children's Hospital of Zhejia… | United States, Argentina, Australia, Belgium, Brazil,… | 2024-07-17 → 2029-01 | Ouvrir |
| NCT06414954 SYNAPSE-MG — Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Pa… |
NMD670 | Myasthénie | Phase 2 | RECRUITING | En attente / non publié | NMD Pharma A/S | United States, Belgium, Denmark, France, Georgia, Ita… | 2024-05-16 → 2026-12 | Ouvrir |
| NCT07677852 MYAOUS — Sexual and Urinary Dysfunctions in Generalized Myasthenia |
MYAOUS — Sexual and Urinary Dysfu… | Myasthénie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Centre Hospitalier Universitaire … | France · APHP and Myology institute, Paris, France | … | 2026-07-30 → 2030-07-30 | Ouvrir |
| NCT06743490 CAPTURE - MG — Capturing Key MG-symptoms Using Smartphone Recordings. |
CAPTURE - MG — Capturing Key MG-s… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Leiden University Medical Center | Netherlands · Leiden University Medical Center, Leide… | 2025-03-18 → 2026-09-30 | Ouvrir |
| NCT06659627 FIT to ACT-MG — Interventions Against Fatigue in Patients With Myasthen… |
FIT to ACT-MG — Interventions Aga… | Myasthénie | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Leiden University Medical Center | Netherlands · Leiden University Medical Center, Leide… | 2024-12-04 → 2027-01-23 | Ouvrir |
| NCT05070858 NIMBLE — A Study to Test How Safe Pozelimab and Cemdisiran Combination … |
Pozelimab + Cemdisiran | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Regeneron Pharmaceuticals | United States, Belgium, Brazil, Canada, China, Denmar… | 2021-12-14 → 2028-11-11 | Ouvrir |
| NCT07714798 Universal STAR-T Cell Injection in Generalized Myasthenia Gravis |
Universal STAR-T Cell | Myasthénie | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Daishi Tian | China · Tongji Hospital Affiliated to Tongji Medical … | 2026-07-06 → 2028-07-06 | Ouvrir |
| NCT07717281 PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis |
PANORAMA: Neuromuscular Organoids… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Fondazione IRCCS Ca' Granda, Ospe… | Italy · Fondazione IRCCS Ca' Granda Ospedale Maggiore… | 2026-06-04 → 2028-03-31 | Ouvrir |
| NCT07673627 ADAPT Forward2 — ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safet… |
Empasiprubart IV | Myasthénie | Phase 2 | RECRUITING | En attente / non publié | argenx | United States · Dent Neurologic Institute - Amherst, … | 2026-07-10 → 2028-04 | Ouvrir |
| NCT06282159 A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthen… |
Claseprubart | Myasthénie | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Dianthus Therapeutics | United States, Argentina, Canada, Czechia, Denmark, F… | 2024-02-23 → 2028-10 | Ouvrir |
| NCT04951622 A Study of Nipocalimab Administered to Adults With Generalized Myasthen… |
Nipocalimab | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Australia, Belgium, Canada, China, Cze… | 2021-07-15 → 2029-03-29 | Ouvrir |
| NCT06558279 ADAPT oculus — A Study to Assess Efficacy and Safety of Efgartigimod PH… |
Efgartigimod PH20 SC | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | argenx | United States, Australia, Austria, Belgium, Canada, C… | 2024-09-18 → 2027-12 | Ouvrir |
| NCT07039916 Study to Assess the Efficacy and Safety of IMVT-1402 in Participants Wi… |
IMVT-1402 | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Immunovant Sciences GmbH | United States, Argentina, Czechia, Denmark, Georgia, … | 2025-05-27 → 2028-12 | Ouvrir |
| NCT07294170 ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Saf… |
Efgartigimod IV | Myasthénie | À vérifier | RECRUITING | En attente / non publié | argenx | United States, Belgium, Germany, Greece, Italy, Japan… | 2025-12-19 → 2028-03-07 | Ouvrir |
| NCT06435312 ziMyG+ — An Open-label Extension Study to Evaluate Subcutaneous Zilucop… |
Zilucoplan | Myasthénie | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | UCB Biopharma SRL | Italy, Poland, South Korea, United Kingdom · Mg0015 2… | 2024-11-19 → 2027-11-19 | Ouvrir |
| NCT07217587 EPIC — Comparative Efficacy of Nipocalimab and Efgartigimod in Particip… |
Nipocalimab | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Israel, Switzerland · Advanced Neurolo… | 2026-01-05 → 2029-01-29 | Ouvrir |
| NCT07075627 A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eato… |
A Study to Evaluate the Incidence… | Myasthénie | À vérifier | WITHDRAWN | En attente / non publié | Addario Lung Cancer Medical Insti… | United States · Dana-Farber Cancer Institute, Boston,… | 2025-09 → 2026-12 | Ouvrir |
| NCT06259071 MuSK 1000 — MuSK Myasthenia 1000 Study |
MuSK 1000 — MuSK Myasthenia 1000 … | Myasthénie | À vérifier | RECRUITING | En attente / non publié | George Washington University | United States · George Washington University, Washing… | 2023-08-23 → 2027-12-31 | Ouvrir |
| NCT06298552 ADAPT SERON — A Phase 3 Study to Evaluate the Efficacy and Safety of Ef… |
Efgartigimod IV | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | argenx | United States, Belgium, Canada, China, Cyprus, Czechi… | 2024-04-16 → 2028-06 | Ouvrir |
| NCT06688435 A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR … |
SYS6020 injection | Myasthénie | Phase 1 | RECRUITING | En attente / non publié | CSPC ZhongQi Pharmaceutical Techn… | China · Qilu Hospital, Shandong University, Jinan, Ch… | 2025-03-04 → 2033-05-01 | Ouvrir |
| NCT07247279 Epidemiological Study of Treatment Approaches in AChR-Antibody Positive… |
Epidemiological Study of Treatmen… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | AstraZeneca | Russia · Research Site, Kazan', Russia | Research Sit… | 2025-12-23 → 2029-12-31 | Ouvrir |
| NCT06517758 A Phase III Study to Investigate Efficacy, Safety and Tolerability of I… |
Iptacopan | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Brazil, China, D… | 2024-07-31 → 2032-05-27 | Ouvrir |
| NCT07284420 ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on… |
Efgartigimod IV | Myasthénie | Phase 2 | RECRUITING | En attente / non publié | argenx | United States, Belgium, Germany, Greece, Italy, Japan… | 2025-12-19 → 2028-03-07 | Ouvrir |
| NCT06463587 Efficacy and Safety of a New Formulation of Oral Cladribine Compared Wi… |
Cladribine Low Dose | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Merck Healthcare KGaA, Darmstadt,… | United States, Argentina, Australia, Belgium, Bulgari… | 2024-06-25 → 2030-11-12 | Ouvrir |
| NCT04225871 RAISE-XT — Open-Label Extension of Zilucoplan in Subjects With Generali… |
zilucoplan (RA101495) | Myasthénie | Phase 3 | COMPLETED | En attente / non publié | UCB Biopharma SRL | United States, Canada, France, Germany, Italy, Japan,… | 2019-12-23 → 2026-07-31 | Ouvrir |